课题基金 / 基金详情

The 4th International Conference on GATA Factors and Human Disease

The 4th International Conference on GATA Factors and Human Disease
第四届GATA因素与人类疾病国际会议
批准号:
7331528
负责人:
James Douglas Engel
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-15 至 2008-06-30

项目摘要

项目成果

James Douglas Engel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The six members of the GATA transcription factor family have now been shown to be vital for numerous distinct developmental events and for the differentiation of multiple organs and cell lineages, including the fat, blood, cardiovascular, nervous, skin, liver and urogenital systems. This is a very active field of research that relates directly to the general inquiry of regulation of gene expression during development. This field is also of immediate medical importance, since it has been shown that a GATA factor is responsible for the increased incidence in one form of leukemia among Downs' syndrome patients (mutations in GATA1) and mutation of a different GATA factor (GATA3) leads to human HDR syndrome, a haploinsufficient disorder resulting in hearing loss, kidney malformation and parathyroid endocrine dysfunction. Even more recently, mutations in GATA4 have been shown to be associated with congenital heart disease. We believe that these highly focused conferences on the GATA factors held every three years have played a seminal role in illuminating numerous developmental pathways of immediate importance in understanding human disease, and we anticipate that this conference will similarly lead to new collaborations and an even deeper understanding of how ineffective gene regulation by these proteins lead to human disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Michigan Kidney, Urology and Hematology Research Training Network
Administrative Core
Administrative Core
Identification of novel y-globin corepressors and advanced inhibitor development
海外基金